| HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa JW Eaton, LF Johnson, JA Salomon, T Bärnighausen, E Bendavid, ... PLoS Medicine 9 (7), e1001245, 2012 | 457 | 2012 |
| Maternal and neonatal outcomes of elective induction of labor AB Caughey, V Sundaram, AJ Kaimal, YW Cheng, A Gienger, SE Little, ... Agency for Healthcare Research and Quality (US), 2009 | 319 | 2009 |
| Nursing home staff networks and COVID-19 MK Chen, JA Chevalier, EF Long Proceedings of the National Academy of Sciences 118 (1), 2021 | 219 | 2021 |
| The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States EF Long, ML Brandeau, DK Owens Annals of Internal Medicine 153 (12), 778-789, 2010 | 219 | 2010 |
| Comparative survival and cost effectiveness of advanced therapies for end-stage heart failure EF Long, GW Swain, AA Mangi Circulation: Heart Failure 7 (3), 470-478, 2014 | 148 | 2014 |
| A conceptual framework for improving critical care patient flow and bed use KS Mathews, EF Long Annals of the American Thoracic Society 12 (6), 886-894, 2015 | 106 | 2015 |
| Spatial resource allocation for emerging epidemics: A comparison of greedy, myopic, and dynamic policies EF Long, E Nohdurft, S Spinler Manufacturing & Service Operations Management 20 (2), 181-198, 2018 | 103 | 2018 |
| HIV treatment as prevention: Models, data, and questions The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group PLoS Medicine 9 (7), e1001259, 2012 | 101 | 2012 |
| Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia EF Long, ML Brandeau, CM Galvin, T Vinichenko, SP Tole, A Schwartz, ... AIDS 20 (17), 2207-2215, 2006 | 96 | 2006 |
| Cost-effectiveness of elective induction of labor at 41 weeks in nulliparous women AJ Kaimal, SE Little, AO Odibo, DM Stamilio, WA Grobman, EF Long, ... American Journal of Obstetrics and Gynecology 204 (2), 137. e1-137. e9, 2011 | 87 | 2011 |
| Controlling co-epidemics: Analysis of HIV and tuberculosis infection dynamics EF Long, NK Vaidya, ML Brandeau Operations Research 56 (6), 1366-1381, 2008 | 86 | 2008 |
| Political Storms: Emergent Partisan Skepticism of Hurricane Risks EF Long, MK Chen, R Rohla Science Advances 6 (37), eabb7906, 2020 | 71 | 2020 |
| The Boarding Patient: Effects of ICU and Hospital Occupancy Surges on Patient Flow EF Long, KS Mathews Production and Operations Management 27 (12), 2122-2143, 2018 | 64 | 2018 |
| The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the United States JL Juusola, ML Brandeau, EF Long, DK Owens, E Bendavid AIDS 25 (14), 1779-1787, 2011 | 58 | 2011 |
| Portfolios of biomedical HIV interventions in South Africa: A cost-effectiveness analysis EF Long, RR Stavert Journal of General Internal Medicine 28 (10), 1294-301, 2013 | 57 | 2013 |
| Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke CG Patil, EF Long, MG Lansberg Journal of Neurosurgery 110 (3), 508-513, 2009 | 56 | 2009 |
| HIV Screening via Fourth-Generation Immunoassay or Nucleic Acid Amplification Test in the United States: A Cost-Effectiveness Analysis EF Long PLoS ONE 6 (11), e27625, 2011 | 48 | 2011 |
| Cost-effectiveness of universal BRCA1/2 screening: evidence-based decision making EF Long, PA Ganz JAMA Oncology 1 (9), 1217-1218, 2015 | 47 | 2015 |
| HIV epidemic control—a model for optimal allocation of prevention and treatment resources SS Alistar, EF Long, ML Brandeau, EJ Beck Health Care Management Science 17 (2), 162-181, 2014 | 46 | 2014 |
| Cost-effectiveness Analysis of Palbociclib or Ribociclib in the Treatment of Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer B Zhang, EF Long Breast Cancer Research and Treatment 175, 778-779, 2019 | 45 | 2019 |